Standard

AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses. / Gillissen, M. A.; de Jong, G.; Levie, S. E. et al.

In: Bone marrow transplantation, Vol. 51, No. 9, 2016, p. 1245-1248.

Research output: Contribution to journalComment/Letter to the editorAcademic

Harvard

Gillissen, MA, de Jong, G, Levie, SE, Yasuda, E, Bakker, AQ, Evers, LM, Pals, ST, Huisman, C, van Helden, PM, Spits, H & Hazenberg, MD 2016, 'AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses', Bone marrow transplantation, vol. 51, no. 9, pp. 1245-1248. https://doi.org/10.1038/bmt.2016.90

APA

Gillissen, M. A., de Jong, G., Levie, S. E., Yasuda, E., Bakker, A. Q., Evers, L. M., Pals, S. T., Huisman, C., van Helden, P. M., Spits, H., & Hazenberg, M. D. (2016). AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses. Bone marrow transplantation, 51(9), 1245-1248. https://doi.org/10.1038/bmt.2016.90

Vancouver

Gillissen MA, de Jong G, Levie SE, Yasuda E, Bakker AQ, Evers LM et al. AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses. Bone marrow transplantation. 2016;51(9):1245-1248. https://doi.org/10.1038/bmt.2016.90

Author

Gillissen, M. A. ; de Jong, G. ; Levie, S. E. et al. / AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses. In: Bone marrow transplantation. 2016 ; Vol. 51, No. 9. pp. 1245-1248.

BibTeX

@article{cf73e9cf222542f19c6b0861a27bceb5,
title = "AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses",
author = "Gillissen, {M. A.} and {de Jong}, G. and Levie, {S. E.} and E. Yasuda and Bakker, {A. Q.} and Evers, {L. M.} and Pals, {S. T.} and C. Huisman and {van Helden}, {P. M.} and H. Spits and Hazenberg, {M. D.}",
year = "2016",
doi = "10.1038/bmt.2016.90",
language = "English",
volume = "51",
pages = "1245--1248",
journal = "Bone marrow transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "9",

}

RIS

TY - JOUR

T1 - AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses

AU - Gillissen, M. A.

AU - de Jong, G.

AU - Levie, S. E.

AU - Yasuda, E.

AU - Bakker, A. Q.

AU - Evers, L. M.

AU - Pals, S. T.

AU - Huisman, C.

AU - van Helden, P. M.

AU - Spits, H.

AU - Hazenberg, M. D.

PY - 2016

Y1 - 2016

U2 - 10.1038/bmt.2016.90

DO - 10.1038/bmt.2016.90

M3 - Comment/Letter to the editor

C2 - 27088384

VL - 51

SP - 1245

EP - 1248

JO - Bone marrow transplantation

JF - Bone marrow transplantation

SN - 0268-3369

IS - 9

ER -

ID: 2901065